Head-To-Head Comparison: Fresenius Medical Care Corporation (FMS) versus Its Competitors
Fresenius Medical Care Corporation (NYSE: FMS) is one of 50 public companies in the “Healthcare Facilities & Services” industry, but how does it compare to its rivals? We will compare Fresenius Medical Care Corporation to similar companies based on the strength of its valuation, dividends, earnings, analyst recommendations, institutional ownership, profitability and risk.
Valuation and Earnings
This table compares Fresenius Medical Care Corporation and its rivals revenue, earnings per share (EPS) and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Fresenius Medical Care Corporation||$20.52 billion||$3.75 billion||22.49|
|Fresenius Medical Care Corporation Competitors||$5.89 billion||$843.94 million||34.49|
Fresenius Medical Care Corporation has higher revenue and earnings than its rivals. Fresenius Medical Care Corporation is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
This is a summary of current ratings and recommmendations for Fresenius Medical Care Corporation and its rivals, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Fresenius Medical Care Corporation||0||3||7||0||2.70|
|Fresenius Medical Care Corporation Competitors||264||1566||1963||38||2.46|
Fresenius Medical Care Corporation presently has a consensus target price of $46.00, suggesting a potential downside of 6.18%. As a group, “Healthcare Facilities & Services” companies have a potential downside of 8.37%. Given Fresenius Medical Care Corporation’s stronger consensus rating and higher probable upside, research analysts plainly believe Fresenius Medical Care Corporation is more favorable than its rivals.
Volatility & Risk
Fresenius Medical Care Corporation has a beta of 0.48, suggesting that its share price is 52% less volatile than the S&P 500. Comparatively, Fresenius Medical Care Corporation’s rivals have a beta of 1.02, suggesting that their average share price is 2% more volatile than the S&P 500.
Institutional & Insider Ownership
2.6% of Fresenius Medical Care Corporation shares are owned by institutional investors. Comparatively, 74.7% of shares of all “Healthcare Facilities & Services” companies are owned by institutional investors. 12.4% of shares of all “Healthcare Facilities & Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
This table compares Fresenius Medical Care Corporation and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Fresenius Medical Care Corporation||7.06%||11.57%||4.97%|
|Fresenius Medical Care Corporation Competitors||9.01%||-0.91%||0.51%|
Fresenius Medical Care Corporation pays an annual dividend of $0.37 per share and has a dividend yield of 0.8%. Fresenius Medical Care Corporation pays out 17.0% of its earnings in the form of a dividend. As a group, “Healthcare Facilities & Services” companies pay a dividend yield of 1.0% and pay out 58.7% of their earnings in the form of a dividend.
Fresenius Medical Care Corporation beats its rivals on 8 of the 15 factors compared.
About Fresenius Medical Care Corporation
Fresenius Medical Care AG & Co. KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment. The Company develops and manufactures a range of dialysis machines, systems and disposable products. As of December 31, 2016, the Company sold its products to customers in more than 120 countries and also used in its internal healthcare service operations. The Company’s Care Coordination services include coordinated delivery of pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services, ambulatory surgery center services and urgent care services.
Receive News & Stock Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related stocks with our FREE daily email newsletter.